Cosmetic procedures need tighter regulation to reduce harm, argue experts

Consistent regulation alongside public education and advertising controls essential to safeguard patients and reduce cosmetic tourism The rise in invasive cosmetic procedures demands tighter regulation, better consumer protection, and greater awareness to protect patient safety and reduce cosmetic tourism, argue experts in The BMJ today. The global market for cosmetic procedures is ...

2026-03-12T10:02:37+00:0012 March 2026|Press release, The BMJ|

Further evidence of developmental risks linked to epilepsy drugs in pregnancy

Study adds weight to previously reported risks and calls for monitoring of new antiseizure drugs Findings published by The BMJ today reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental disorders such as ADHD and autism in children, and indicate no substantial risk for several other antiseizure ...

2026-03-12T09:56:41+00:0012 March 2026|Press release, The BMJ|

First degree female relatives’ suicidal intentions may influence women’s suicide risk

Sex specific effects of shared familial environment and other social factors may be key Genetic factors only partly explain observed sex difference in suicidal behaviours  A woman’s suicide risk may be influenced by the suicidal intention of her female first degree relatives, with sex specific effects of a shared familial ...

2026-03-11T10:14:16+00:0011 March 2026|BMJ Mental Health, Press release|

Specific gut bacteria species (R inulinivorans) linked to muscle strength

Converts muscle fibres to ‘fast-twitch’ (type II), designed for short intensive movement Holds promise as nutraceutical for treating age-related muscle wasting, say researchers A species of gut bacteria called Roseburia inulinivorans is specifically associated with human muscle strength and improved muscular performance in mice, finds research published online in the journal Gut.  R ...

2026-03-11T10:07:44+00:0011 March 2026|Gut, Press release|

Wegovy may have highest ‘eye stroke’ and sight loss risk of semaglutide GLP-1 agonists

Odds of ischaemic optic neuropathy nearly 5 times higher than among users of Ozempic And 3 times higher in men than in women, analysis of unintended side effect reports shows  Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of ‘eye stroke’ (ischaemic optic neuropathy) and sudden ...

Research4Life marks 25 years of expanding who gets to participate in global research

Geneva, March 4, 2025 – What began as a bold response to a call from the United Nations has grown into one of the most enduring public-private partnerships for research equity. For 25 years, Research4Life has expanded access to trusted academic and professional resources –  transforming who gets to participate ...

2026-03-10T08:42:33+00:005 March 2026|Corporate announcement, Press release|

Councils face industry legal threats for campaigns warning against wood burning stoves 

As the UK government considers health warnings for new stoves, investigation reveals industry pressure on councils to shut down clean air campaigns As the UK government considers adding health warnings to new wood burning stoves, as part of a public consultation on solid fuel burning, councils in England are being threatened with ...

2026-03-10T08:49:39+00:005 March 2026|Press release, The BMJ|

GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death

Findings suggest a potential role in both prevention and treatment of various substance use disorders, say researchers Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of substances including alcohol, cannabis, cocaine, nicotine, and ...

2026-03-03T17:04:54+00:005 March 2026|Press release, The BMJ|

7 hours 18 mins may be optimal sleep length for avoiding type 2 diabetes precursor

Weekend catch-ups linked to heightened risk of insulin resistance in those sleeping more Sleeping for 7 hours and 18 minutes every night may be the sweet spot for warding off the risk of insulin resistance—the precursor to type 2 diabetes—suggests a large observational study published in the open access journal BMJ ...

Go to Top